ValenzaBio partners ProBioGen to maximize cell line productivity in Europe

Biologics |  News | 0 Comment | 09 Aug, 2021

ProBioGen and ValenzaBio jointly initiate a cell line development project involving the application of ProBioG...Read more

Bioreactor sales upsurge with ramped-up COVID-19 vaccine production

Biologics |  Opinion | 0 Comment | 25 May, 2021

Bioreactor technology has evolved over time and is still expanding as its requirements in biopharmaceutical and biotechn...Read more

BeiGene receives manufacturing approval for biologics facility in China

Biologics |  News | 0 Comment | 08 Apr, 2021

BeiGene, Ltd., a commercial-stage biotechnology company focused on developing and commercializing innovative medicines w...Read more

Abu Dhabi based ADQ invests Rs 555 crore in Biocon Biologics

Biologics |  News | 0 Comment | 08 Jan, 2021

Biocon Ltd, an innovation-led global biopharmaceuticals company based in India, announced that the Board of its subsidia...Read more

Celltrion to invest $520M for new plant in China

Biologics |  News | 0 Comment | 24 Jan, 2020

South Korea's Celltrion Inc. said it will spend 600 billion won (US$520 million) on its new plant in China over the next...Read more

Singapore to host 7th Annual Biologics Manufacturing Asia 2020

Biologics |  News | 0 Comment | 28 Oct, 2019

The biologics industry in Asia- Pacific is estimated to be the fastest-growing market in the world. For instance, Asia- ...Read more

Biocon Biologics expands R&D footprint

Biologics |  News | 0 Comment | 24 Sep, 2019

Asia’s premier biopharmaceuticals company, has announced that its subsidiary, Biocon Biologics, has acquired R&...Read more

I-Mab gets IND approval for TJC4 antibody

Biologics |  News | 0 Comment | 15 Jul, 2019

I-Mab Biopharma ("I-Mab"), a clinical stage biotech company exclusively focusing on discovery and development of innovat...Read more

Potential treatment strategies for human cancer uncovered in bats

Biologics |  News | 1 Comment | 02 Jul, 2019

Researchers from Duke-NUS Medical School, Singapore have uncovered a potential mechanism behind cancer suppression in ba...Read more

NMPA accepts NDA for biosimilar product candidate of Rituximab

Biologics |  News | 0 Comment | 27 Jun, 2019

Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (N...Read more

Biocon Biologics receive EU GMP Certification

Biologics |  News | 0 Comment | 14 Jun, 2019

Biocon has received the Certificate of GMP compliance from EMA for its Biologics Drug Product (DP) as well as Drug Subst...Read more

NTU team explore binding secrets of superglue protein

Biologics |  News | 0 Comment | 06 Jun, 2019

Scientists from Nanyang Technological University, Singapore (NTU Singapore) have pinpointed how a special class of plant...Read more

Alphamab completes $60 M Series B Financing

Biologics |  News | 0 Comment | 29 May, 2019

Alphamab Oncology, a leading biopharmaceutical company based in China dedicated to global development of innovative biol...Read more

Signalling protein may unleash the potential of drug-based therapies to treat hyperparathyroidism

Biologics |  News | 0 Comment | 28 May, 2019

Researchers at Duke-NUS Medical School, Singapore have discovered “Sema3d”, a signalling protein that appear...Read more

EMA accepts Prestige Biopharma's MAA for review

Biologics |  News | 0 Comment | 28 May, 2019

Prestige BioPharma has announced that European Medicines Agency (EMA) has validated and accepted for review the Mar...Read more

Translational research led by Singapore scientists uncovers new treatment for fatty liver disease

Biologics |  News | 0 Comment | 24 May, 2019

A team of researchers at Singapore that deactivating a specific protein − interleukin 11 (IL11) – with drugs...Read more

WuXi Biologics commences construction of center for Innovative Biologics

Biologics |  News | 0 Comment | 17 May, 2019

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...Read more

Takeda's BLA for Vedolizumab gets approval by U.S. FDA

Biologics |  News | 0 Comment | 14 May, 2019

Takeda Pharmaceutical Company has announced that the U.S. Food & Drug Administration (FDA) has accepted for rev...Read more